IRIS
GALDIERO, MARIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 644
EU - Europa 308
AS - Asia 300
AF - Africa 10
Totale 1.262
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 624
CN - Cina 112
SG - Singapore 102
SE - Svezia 82
HK - Hong Kong 59
IT - Italia 50
DE - Germania 46
FI - Finlandia 41
NL - Olanda 34
IE - Irlanda 32
CA - Canada 13
CI - Costa d'Avorio 10
IR - Iran 9
UA - Ucraina 9
GB - Regno Unito 7
MX - Messico 7
IQ - Iraq 6
IN - India 4
VN - Vietnam 4
FR - Francia 3
ID - Indonesia 3
RO - Romania 2
RU - Federazione Russa 2
KR - Corea 1
Totale 1.262
Salva come PNG Salva come JPEG
Città #
Chandler 139
Singapore 83
Hong Kong 59
Millbury 41
Amsterdam 34
Princeton 32
Santa Clara 28
Ashburn 27
Nanjing 27
Jacksonville 23
Beijing 19
Wilmington 18
Naples 15
Ann Arbor 13
Napoli 13
Ottawa 13
Boston 11
Seattle 11
Helsinki 10
Ardabil 7
Falls Church 7
Hebei 7
Nanchang 7
Des Moines 6
Falkenstein 6
Kronberg 6
Shenyang 6
Augusta 4
Changsha 4
Dong Ket 4
Mexico 4
Munich 4
Boardman 3
Guangzhou 3
Indiana 3
Kunming 3
New York 3
Redmond 3
Tianjin 3
Wonogiri 3
Zapopan 3
Bucharest 2
Castelnuovo Rangone 2
Dublin 2
Fiumicino 2
Jiaxing 2
Lanzhou 2
Monmouth Junction 2
Norwalk 2
Rome 2
San Francisco 2
San Mateo 2
Shanghai 2
Avellino 1
Clifton 1
Genzano Di Lucania 1
Handan 1
Jinhua 1
Kish 1
Meridian 1
Mumbai 1
Ningbo 1
Paris 1
Prata Di Principato Ultra 1
Pune 1
Qingdao 1
Redwood City 1
San Giuseppe Vesuviano 1
Seoul 1
Shijiazhuang 1
Suzhou 1
Tappahannock 1
Trecase 1
Washington 1
Yellow Springs 1
Totale 761
Salva come PNG Salva come JPEG
Nome #
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 69
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients 62
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 57
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 57
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism. 57
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 55
The role of vitamin D in male fertility: A focus on the testis 55
[Chronic kidney disease: fertility and sexuality] 50
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 47
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 45
Effects of initial therapy for five years with somatostatin analogs foracromegaly on growth hormone and insulin-like growth factor-I levels, tumorshrinkage, and cardiovascular disease: a prospective study. 45
Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. 42
Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-monthstudy. 42
New perspectives in the medical treatment of acromegaly 39
Acromegaly and the cardiovascular system 39
Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study 38
Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas 38
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. 37
Effect of Cabergoline on Metabolism in Prolactinomas. 37
Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. 37
Circulating endothelial progenitor cells in acromegaly. 34
Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia. 33
Growth hormone, prolactin, and sexuality. 32
Beneficial effect of dose escalation of octreotide-LAR as first-line therapy in patients with acromegaly. 31
The role of dopamine pathway on human sperm: in vitro effect of dopamine receptor agonists and antagonists on sperm motility, kinetics and viability 31
Impact of Somatostatin Analogs vs. Surgery on glucose metabolism in acromegaly: Results of a 5 years observational, open, prospective study 29
Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months. 27
Medical consequences of acromegaly: what are the effects of biochemical control? 26
Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy 25
Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance 25
Cushing, acromegaly, GH deficiency and tendons 25
Erectile dysfunction is common ammong men with acromegaly and is associated with morbidities related to the disease 21
Treatment with GH receptor antagonist in acromegaly:effect on cardiac arrhythmias. 19
Totale 1.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.302
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 0 0 0 0 0 0 0 0 0 4 20 18
2020/2021102 2 2 19 2 3 20 2 2 8 7 27 8
2021/2022242 6 0 0 3 7 35 3 8 39 9 56 76
2022/2023282 36 31 14 25 34 29 1 20 44 37 9 2
2023/2024169 11 29 28 13 10 12 2 24 3 0 25 12
2024/2025250 46 57 6 5 20 49 67 0 0 0 0 0
Totale 1.306